CARDIEX LIMITED - Announcements

11.1%

3.2¢

Market Cap $17.60M

Technology Scientific & Technical Instruments

CardieX Limited is an Australia-based digital health technology company. The Company... CardieX Limited is an Australia-based digital health technology company. The Company develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. It specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

CDX	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/13	177.24KB	Share
CDX	New study strongly supports measurement of central pressures	PRICE SENSITIVE	19/04/13	21.51KB	Share
CDX	Ceasing to be a substantial holder		04/03/13	43.85KB	Share
CDX	Change in substantial holding		04/03/13	64.17KB	Share
CDX	US$0.8million pharmaceutical trial contract expansion	PRICE SENSITIVE	25/02/13	18.56KB	Share
CDX	AtCor reports $2.3 million profit for H1 FY2103		21/02/13	38.1KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/13	800.84KB	Share
CDX	AtCor to report profit for H1 FY2013	PRICE SENSITIVE	31/01/13	44.22KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	22/01/13	177.18KB	Share
CDX	Tax refund	PRICE SENSITIVE	18/12/12	64.71KB	Share
CDX	US$350,000 order for publicly funded study	PRICE SENSITIVE	05/12/12	64.69KB	Share
CDX	SphygmoCor XCEL receives US FDA clearance	PRICE SENSITIVE	20/11/12	47.29KB	Share
CDX	Change of Director's Interest Notice		15/11/12	111KB	Share
CDX	Change of Director's Interest Notice		31/10/12	111.15KB	Share
CDX	Appendix 3B		31/10/12	171.73KB	Share
CDX	Change in substantial holding		30/10/12	132.52KB	Share
CDX	Results of Meeting		26/10/12	17.25KB	Share
CDX	Chairmans address to 2012 AGM		26/10/12	74.23KB	Share
CDX	Investor Presentation		22/10/12	1.19MB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	18/10/12	176.74KB	Share
CDX	US$3.2 million pharmaceutical trial contract	PRICE SENSITIVE	08/10/12	18.64KB	Share
CDX	Annual Report to shareholders		26/09/12	1.35MB	Share
CDX	Notice of Annual General Meeting/Proxy Form		26/09/12	2.18MB	Share
CDX	New study finds arterial stiffness precedes hypertension		21/09/12	44.93KB	Share
CDX	Full Year Statutory Accounts	PRICE SENSITIVE	23/08/12	3.06MB	Share
CDX	Change of Director's Interest Notice x 5		14/08/12	176.94KB	Share
CDX	US$1.1 million pharmaceutical contract	PRICE SENSITIVE	13/08/12	18.54KB	Share
CDX	Appendix 3B		09/08/12	164.36KB	Share
CDX	Results of Meeting		09/08/12	19.81KB	Share
CDX	Chairman's Address to Shareholders	PRICE SENSITIVE	08/08/12	65.4KB	Share
CDX	Form 603 & Form 604		03/08/12	159.45KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/12	177.16KB	Share
CDX	FDA submission for next generation product		23/07/12	65.19KB	Share
CDX	Notice of General Meeting/Proxy Form		06/07/12	288.47KB	Share
CDX	Business Update	PRICE SENSITIVE	04/07/12	65.52KB	Share
CDX	Becoming a substantial holder		28/06/12	79.21KB	Share
CDX +ALF	Change in substantial holding from ALF		25/06/12	37.13KB	Share
CDX	Share trading policy - Update		15/06/12	55.44KB	Share
CDX	Success share placement	PRICE SENSITIVE	15/06/12	65.19KB	Share
CDX	Reinstatement to Official Quotation	PRICE SENSITIVE	15/06/12	23.48KB	Share
CDX	Cleansing notice		15/06/12	65.16KB	Share
CDX	Appendix 3B		15/06/12	164.38KB	Share
CDX	Suspension from Official Quotation	PRICE SENSITIVE	14/06/12	90.62KB	Share
CDX	Trading Halt	PRICE SENSITIVE	12/06/12	86.93KB	Share
CDX	AtCor to enter new market segment	PRICE SENSITIVE	07/06/12	67.08KB	Share
CDX	Acquisition of Alliance Partner SunTech by Halma plc	PRICE SENSITIVE	05/06/12	68.54KB	Share
CDX	Investor Presentation		15/05/12	719.67KB	Share
CDX	Ground breaking new product launched and European Congress		01/05/12	182.17KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	24/04/12	177.41KB	Share
CDX	New CPT code to be established	PRICE SENSITIVE	07/03/12	66.63KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	16/02/12	1.56MB	Share
CDX	AtCor awarded $1.1 million Commercialisation Australia grant	PRICE SENSITIVE	02/02/12	25KB	Share
CDX	First half market update	PRICE SENSITIVE	31/01/12	34.11KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/12	177.59KB	Share
CDX	Strategic Alliance with SunTech Medical	PRICE SENSITIVE	23/01/12	66.54KB	Share
CDX	Ceasing to be a substantial holder		12/01/12	49.58KB	Share
CDX	Three US medical associations support central BP assessment	PRICE SENSITIVE	11/01/12	192.08KB	Share
CDX +ALF	Change in substantial holding from ALF		06/12/11	41.33KB	Share
CDX	US$0.9 million pharmaceutical contract	PRICE SENSITIVE	02/11/11	18.87KB	Share
CDX	Appendix 3B		28/10/11	186.56KB	Share
CDX	Change of Director's Interest Notice		27/10/11	111.13KB	Share
CDX	Results of Meeting		21/10/11	17.39KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	21/10/11	176.98KB	Share
CDX	Chairmans Address		21/10/11	19.94KB	Share
CDX	Presentation to Shareholders		21/10/11	265.33KB	Share
CDX	Positive Medicare ruling in New York State	PRICE SENSITIVE	13/10/11	59.75KB	Share
CDX	US$1.86 million new pharmaceutical contracts	PRICE SENSITIVE	10/10/11	33KB	Share
CDX	Annual Report to shareholders		20/09/11	1.57MB	Share
CDX	Proxy voting form		20/09/11	241KB	Share
CDX	Notice of Annual General Meeting		20/09/11	433.95KB	Share
CDX	Change in substantial holding		02/09/11	106.91KB	Share
CDX +ALF	Change in substantial holding from ALF		29/08/11	22.44KB	Share
CDX	FY2012 revenue update	PRICE SENSITIVE	29/08/11	30.46KB	Share
CDX	Preliminary Final Report	PRICE SENSITIVE	26/08/11	3.02MB	Share
CDX	Market Update	PRICE SENSITIVE	28/07/11	35.42KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/11	177.55KB	Share
CDX	Worldwide agreement with SunTech Medical	PRICE SENSITIVE	27/07/11	54.23KB	Share
CDX	Ceasing to be a substantial holder		18/07/11	60.26KB	Share
CDX	Change in substantial holding		07/07/11	100.85KB	Share
CDX	US$1.25 million new pharmaceutical contracts	PRICE SENSITIVE	01/07/11	33.01KB	Share
CDX	Change in substantial holding		27/06/11	141.17KB	Share
CDX +ALF	Change in substantial holding from ALF		24/06/11	22.4KB	Share
CDX	Change of Directors Interest Notice - Revision		18/05/11	132.61KB	Share
CDX	Outstanding options		17/05/11	22.89KB	Share
CDX	Change of Director's Interest Notice		17/05/11	18.3KB	Share
CDX	Lowering central blood pressure shown to reverse heart damag		17/05/11	27.04KB	Share
CDX	Investor presentation		06/05/11	456.25KB	Share
CDX +ALF	Becoming a substantial holder from ALF		05/05/11	25.21KB	Share
CDX	Becoming a substantial holder		05/05/11	154.66KB	Share
CDX	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/11	211.27KB	Share
CDX	Shareholder update		12/04/11	353.67KB	Share
CDX +SHL	Sonic Healthcare's Lifescreen to offer SphygmoCor test	PRICE SENSITIVE	05/04/11	26.32KB	Share
CDX	Breaking Study New Alternative in Aortic Pressure Monitoring	PRICE SENSITIVE	28/03/11	67.46KB	Share
CDX	US$0.6 million new pharmaceutical contract	PRICE SENSITIVE	08/03/11	65.01KB	Share
CDX	Change in substantial holding		08/03/11	109.21KB	Share
CDX	15-year Taiwanese study endorses central BP measurement	PRICE SENSITIVE	04/03/11	27.59KB	Share
CDX	Change in substantial holding - Amended		23/02/11	111KB	Share
CDX	Change in substantial holding		23/02/11	109.54KB	Share
CDX	Half Yearly Report and Accounts	PRICE SENSITIVE	17/02/11	194.09KB	Share
CDX	Becoming a substantial holder		04/02/11	112.27KB	Share

CDX Appendix 4C - quarterly
23/04/13	PRICE SENSITIVE	177.24KB	Share
CDX New study strongly supports measurement of central pressures
19/04/13	PRICE SENSITIVE	21.51KB	Share
CDX Ceasing to be a substantial holder
04/03/13		43.85KB	Share
CDX Change in substantial holding
04/03/13		64.17KB	Share
CDX US$0.8million pharmaceutical trial contract expansion
25/02/13	PRICE SENSITIVE	18.56KB	Share
CDX AtCor reports $2.3 million profit for H1 FY2103
21/02/13		38.1KB	Share
CDX Half Yearly Report and Accounts
21/02/13	PRICE SENSITIVE	800.84KB	Share
CDX AtCor to report profit for H1 FY2013
31/01/13	PRICE SENSITIVE	44.22KB	Share
CDX Appendix 4C - quarterly
22/01/13	PRICE SENSITIVE	177.18KB	Share
CDX Tax refund
18/12/12	PRICE SENSITIVE	64.71KB	Share
CDX US$350,000 order for publicly funded study
05/12/12	PRICE SENSITIVE	64.69KB	Share
CDX SphygmoCor XCEL receives US FDA clearance
20/11/12	PRICE SENSITIVE	47.29KB	Share
CDX Change of Director's Interest Notice
15/11/12		111KB	Share
CDX Change of Director's Interest Notice
31/10/12		111.15KB	Share
CDX Appendix 3B
31/10/12		171.73KB	Share
CDX Change in substantial holding
30/10/12		132.52KB	Share
CDX Results of Meeting
26/10/12		17.25KB	Share
CDX Chairmans address to 2012 AGM
26/10/12		74.23KB	Share
CDX Investor Presentation
22/10/12		1.19MB	Share
CDX Appendix 4C - quarterly
18/10/12	PRICE SENSITIVE	176.74KB	Share
CDX US$3.2 million pharmaceutical trial contract
08/10/12	PRICE SENSITIVE	18.64KB	Share
CDX Annual Report to shareholders
26/09/12		1.35MB	Share
CDX Notice of Annual General Meeting/Proxy Form
26/09/12		2.18MB	Share
CDX New study finds arterial stiffness precedes hypertension
21/09/12		44.93KB	Share
CDX Full Year Statutory Accounts
23/08/12	PRICE SENSITIVE	3.06MB	Share
CDX Change of Director's Interest Notice x 5
14/08/12		176.94KB	Share
CDX US$1.1 million pharmaceutical contract
13/08/12	PRICE SENSITIVE	18.54KB	Share
CDX Appendix 3B
09/08/12		164.36KB	Share
CDX Results of Meeting
09/08/12		19.81KB	Share
CDX Chairman's Address to Shareholders
08/08/12	PRICE SENSITIVE	65.4KB	Share
CDX Form 603 & Form 604
03/08/12		159.45KB	Share
CDX Appendix 4C - quarterly
31/07/12	PRICE SENSITIVE	177.16KB	Share
CDX FDA submission for next generation product
23/07/12		65.19KB	Share
CDX Notice of General Meeting/Proxy Form
06/07/12		288.47KB	Share
CDX Business Update
04/07/12	PRICE SENSITIVE	65.52KB	Share
CDX Becoming a substantial holder
28/06/12		79.21KB	Share
CDX +ALF Change in substantial holding from ALF
25/06/12		37.13KB	Share
CDX Share trading policy - Update
15/06/12		55.44KB	Share
CDX Success share placement
15/06/12	PRICE SENSITIVE	65.19KB	Share
CDX Reinstatement to Official Quotation
15/06/12	PRICE SENSITIVE	23.48KB	Share
CDX Cleansing notice
15/06/12		65.16KB	Share
CDX Appendix 3B
15/06/12		164.38KB	Share
CDX Suspension from Official Quotation
14/06/12	PRICE SENSITIVE	90.62KB	Share
CDX Trading Halt
12/06/12	PRICE SENSITIVE	86.93KB	Share
CDX AtCor to enter new market segment
07/06/12	PRICE SENSITIVE	67.08KB	Share
CDX Acquisition of Alliance Partner SunTech by Halma plc
05/06/12	PRICE SENSITIVE	68.54KB	Share
CDX Investor Presentation
15/05/12		719.67KB	Share
CDX Ground breaking new product launched and European Congress
01/05/12		182.17KB	Share
CDX Appendix 4C - quarterly
24/04/12	PRICE SENSITIVE	177.41KB	Share
CDX New CPT code to be established
07/03/12	PRICE SENSITIVE	66.63KB	Share
CDX Half Yearly Report and Accounts
16/02/12	PRICE SENSITIVE	1.56MB	Share
CDX AtCor awarded $1.1 million Commercialisation Australia grant
02/02/12	PRICE SENSITIVE	25KB	Share
CDX First half market update
31/01/12	PRICE SENSITIVE	34.11KB	Share
CDX Appendix 4C - quarterly
31/01/12	PRICE SENSITIVE	177.59KB	Share
CDX Strategic Alliance with SunTech Medical
23/01/12	PRICE SENSITIVE	66.54KB	Share
CDX Ceasing to be a substantial holder
12/01/12		49.58KB	Share
CDX Three US medical associations support central BP assessment
11/01/12	PRICE SENSITIVE	192.08KB	Share
CDX +ALF Change in substantial holding from ALF
06/12/11		41.33KB	Share
CDX US$0.9 million pharmaceutical contract
02/11/11	PRICE SENSITIVE	18.87KB	Share
CDX Appendix 3B
28/10/11		186.56KB	Share
CDX Change of Director's Interest Notice
27/10/11		111.13KB	Share
CDX Results of Meeting
21/10/11		17.39KB	Share
CDX Appendix 4C - quarterly
21/10/11	PRICE SENSITIVE	176.98KB	Share
CDX Chairmans Address
21/10/11		19.94KB	Share
CDX Presentation to Shareholders
21/10/11		265.33KB	Share
CDX Positive Medicare ruling in New York State
13/10/11	PRICE SENSITIVE	59.75KB	Share
CDX US$1.86 million new pharmaceutical contracts
10/10/11	PRICE SENSITIVE	33KB	Share
CDX Annual Report to shareholders
20/09/11		1.57MB	Share
CDX Proxy voting form
20/09/11		241KB	Share
CDX Notice of Annual General Meeting
20/09/11		433.95KB	Share
CDX Change in substantial holding
02/09/11		106.91KB	Share
CDX +ALF Change in substantial holding from ALF
29/08/11		22.44KB	Share
CDX FY2012 revenue update
29/08/11	PRICE SENSITIVE	30.46KB	Share
CDX Preliminary Final Report
26/08/11	PRICE SENSITIVE	3.02MB	Share
CDX Market Update
28/07/11	PRICE SENSITIVE	35.42KB	Share
CDX Appendix 4C - quarterly
28/07/11	PRICE SENSITIVE	177.55KB	Share
CDX Worldwide agreement with SunTech Medical
27/07/11	PRICE SENSITIVE	54.23KB	Share
CDX Ceasing to be a substantial holder
18/07/11		60.26KB	Share
CDX Change in substantial holding
07/07/11		100.85KB	Share
CDX US$1.25 million new pharmaceutical contracts
01/07/11	PRICE SENSITIVE	33.01KB	Share
CDX Change in substantial holding
27/06/11		141.17KB	Share
CDX +ALF Change in substantial holding from ALF
24/06/11		22.4KB	Share
CDX Change of Directors Interest Notice - Revision
18/05/11		132.61KB	Share
CDX Outstanding options
17/05/11		22.89KB	Share
CDX Change of Director's Interest Notice
17/05/11		18.3KB	Share
CDX Lowering central blood pressure shown to reverse heart damag
17/05/11		27.04KB	Share
CDX Investor presentation
06/05/11		456.25KB	Share
CDX +ALF Becoming a substantial holder from ALF
05/05/11		25.21KB	Share
CDX Becoming a substantial holder
05/05/11		154.66KB	Share
CDX Appendix 4C - quarterly
28/04/11	PRICE SENSITIVE	211.27KB	Share
CDX Shareholder update
12/04/11		353.67KB	Share
CDX +SHLSonic Healthcare's Lifescreen to offer SphygmoCor test
05/04/11	PRICE SENSITIVE	26.32KB	Share
CDX Breaking Study New Alternative in Aortic Pressure Monitoring
28/03/11	PRICE SENSITIVE	67.46KB	Share
CDX US$0.6 million new pharmaceutical contract
08/03/11	PRICE SENSITIVE	65.01KB	Share
CDX Change in substantial holding
08/03/11		109.21KB	Share
CDX 15-year Taiwanese study endorses central BP measurement
04/03/11	PRICE SENSITIVE	27.59KB	Share
CDX Change in substantial holding - Amended
23/02/11		111KB	Share
CDX Change in substantial holding
23/02/11		109.54KB	Share
CDX Half Yearly Report and Accounts
17/02/11	PRICE SENSITIVE	194.09KB	Share
CDX Becoming a substantial holder
04/02/11		112.27KB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.2¢		Change -0.004(11.1%)		Mkt cap ! $17.60M

Open	High	Low	Value	Volume
3.2¢	3.2¢	3.2¢	$6.593K	206.0K

Buyers (Bids)

No.	Vol.	Price($)
2	195000	3.1¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	100000	1

View Market Depth

No.	Vol.	Price($)
2	195000	0.031
7	672138	0.030
1	75000	0.029
2	275000	0.028
2	325000	0.027

Price($)	Vol.	No.
0.033	100000	1
0.034	100000	1
0.036	71197	1
0.037	500000	1
0.038	580000	1

Last trade - 13.09pm 11/08/2025 (20 minute delay)


Last 3.3¢		Change -0.004 ( 0.00 %)
Open	High	Low	Volume
3.3¢	3.3¢	3.1¢	176075
Last updated 15.03pm 11/08/2025 ?

CDX (ASX) Chart

CARDIEX LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories